8.79
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$8.81
Aprire:
$8.83
Volume 24 ore:
725.09K
Relative Volume:
0.94
Capitalizzazione di mercato:
$520.54M
Reddito:
$1.10B
Utile/perdita netta:
$83.60M
Rapporto P/E:
6.1469
EPS:
1.43
Flusso di cassa netto:
$132.30M
1 W Prestazione:
-3.09%
1M Prestazione:
-13.57%
6M Prestazione:
-41.44%
1 anno Prestazione:
-32.38%
Embecta Corp Stock (EMBC) Company Profile
Nome
Embecta Corp
Settore
Industria
Telefono
(862) 401-0000
Indirizzo
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
EMBC
Embecta Corp
|
8.79 | 520.54M | 1.10B | 83.60M | 132.30M | 1.43 |
|
ISRG
Intuitive Surgical Inc
|
472.16 | 167.68B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.36 | 45.33B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.32 | 37.69B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.46 | 33.65B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
230.84 | 33.63B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Iniziato | Mizuho | Neutral |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-10-20 | Iniziato | Wolfe Research | Peer Perform |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | Iniziato | BTIG Research | Neutral |
| 2022-08-01 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-06-21 | Iniziato | BofA Securities | Underperform |
Mostra tutto
Embecta Corp Borsa (EMBC) Ultime notizie
BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating - MSN
The Technical Signals Behind (EMBC) That Institutions Follow - Stock Traders Daily
Embecta Corp. Stock Plummets to New 52-Week Low of $9.06 - Markets Mojo
Embecta Corp. Stock Plummets to New 52-Week Low of $8.81 - Markets Mojo
NanoTess lands Embecta deal to put its tech in 14,000 Canadian pharmacies - BetaKit
Embecta Stock Pre-Market (+6.5%): Enters Wound Care Market with Canadian Distribution Deal - Trefis
Calgary Startup NanoTess Signs Deal with Diabetes Care Leader embecta to Bring Catalytic Wound Care to All Canadians - Yahoo Finance
Jefferies Financial Group Inc. Boosts Stock Position in Embecta Corp. $EMBC - MarketBeat
Embecta (NASDAQ:EMBC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Technical Analysis: Can Embecta Corp withstand a market correctionJuly 2025 Institutional & Weekly Top Gainers Trade List - baoquankhu1.vn
Embecta (NASDAQ:EMBC) Sets New 52-Week LowHere's What Happened - MarketBeat
EMBC SEC FilingsEmbecta Corp 10-K, 10-Q, 8-K Forms - Stock Titan
William Blair Investment Management LLC Sells 312,857 Shares of Embecta Corp. $EMBC - MarketBeat
Precision Trading with Embecta Corp. (EMBC) Risk Zones - Stock Traders Daily
InvestingPro’s Fair Value spotted Embecta overvaluation before 47% drop By Investing.com - Investing.com South Africa
EMBCEmbecta Corp Latest Stock News & Market Updates - Stock Titan
Embecta Corp. (EMBC) Stock Analysis: Attractive Dividend Yield and Significant Upside Potential Beckon Investors - DirectorsTalk Interviews
EMBC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Drivers: Why is Embecta Corp stock going upWeekly Volume Report & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Embecta Corp. (EMBC) Stock Analysis: A 58.28% Potential Upside In Medical Device Innovation - DirectorsTalk Interviews
Public Sector Pension Investment Board Increases Stock Position in Embecta Corp. $EMBC - MarketBeat
Technical Reactions to EMBC Trends in Macro Strategies - Stock Traders Daily
Does Embecta Corp. have high return on assets2025 Volatility Report & Safe Swing Trade Setup Alerts - mfd.ru
Embecta shareholders back board, pay, and equity plan - The Globe and Mail
Will Embecta Corp. stock gain from lower inflationPortfolio Performance Report & High Conviction Buy Zone Alerts - mfd.ru
Why analysts remain bullish on Embecta Corp. stockPortfolio Return Summary & Reliable Price Breakout Signals - mfd.ru
Embecta's (NASDAQ:EMBC) Solid Earnings Have Been Accounted For Conservatively - simplywall.st
Why Embecta's (NASDAQ:EMBC) Earnings Are Better Than They Seem - 富途牛牛
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance
Embecta names CEO Kurdikar as new board chair, picks new lead independent director - Drug Delivery Business
Embecta Corp. Appoints Devdatt Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director - Quiver Quantitative
embecta names new Chairman of the Board and Lead Independent Director - The Manila Times
What’s the RSI of Embecta Corp. stock2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15 - Yahoo Finance
Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction - MSN
Can Embecta Corp. stock surprise with earnings upside2025 Stock Rankings & Low Risk High Reward Trade Ideas - mfd.ru
Embecta Announces Board Changes, Effective February 11, 2026 - marketscreener.com
Embecta (NASDAQ:EMBC) Trading Down 5%Should You Sell? - MarketBeat
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Embecta Corp. Just Recorded A 28% EPS Beat: Here's What Analysts Are Forecasting Next - 富途牛牛
Trading the Move, Not the Narrative: (EMBC) Edition - Stock Traders Daily
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15 - simplywall.st
Embecta Earnings Call: U.S. Headwinds, Global Offsets - The Globe and Mail
Embecta (NASDAQ:EMBC) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
3 Healthcare Stocks Paying the Highest Dividends of 2026 - The Motley Fool
Embecta: Stable Execution, GLP-1–Driven Growth Optionality, and Attractive Valuation Support Buy Rating and $25 Target - TipRanks
BTIG Research Reiterates "Buy" Rating for Embecta (NASDAQ:EMBC) - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG Reiterates Buy Rating on Embecta (EMBC) with Stable Price T - GuruFocus
Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline By Investing.com - Investing.com South Africa
Embecta (EMBC) Margin Rebound And 4.4x P E Challenge Cautious Narratives - simplywall.st
Embecta Corp Azioni (EMBC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):